The beauty giant says the research partnership “offers exciting perspectives at a time when conventional tissue engineering technologies remain limited in terms of the complexity of cell patterns.”
“We’re very proud to be working with L’Oréal. The fact that a world-renowned company is adopting our technology is a major step for Poietis,” said Fabien Guillemot, CEO and chief scientific officer at Poietis.
The laser-assisted bioprinting technology developed by Poietis to produce biological tissue can position cells in 3D with extremely high cellular resolution (on the order of 10 microns) and cellular viability (more than 95%), according to L’Oréal. The resulting living biological tissue must mature for about three weeks before it can be used in tests.
“For L’Oréal, the combination of our respective areas of expertise opens up the possibility of previously unheard of achievements in the field of hair. This research partnership is very stimulating for the advanced research teams,” noted Jose Cotovio, director of predictive methods and models department, L’Oréal Recherche & Innovation.
Poietis and L’Oréal’s multi-year research partnership in the areas of hair biology and hair engineering should ultimately lead to new advances in hair knowledge and enable the development of exclusive efficacy testing on bioprinted hair samples, according to the companies.
Created in September 2014, Poietis, based in Pessac, develops physiological 3D models and partners with pharmaceutical and cosmetics companies. The firm was the winner of the 2014 ILab Contest (French National Competition for Innovative start-up Creation of the Ministry of Research, Creation-Development category) and the 2016 Worldwide Innovation Contest, Poietis is the only company to use this technology initially developed at the INSERM and Bordeaux University.